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Purpose: Claudication patients' perceptions of walking impairment often influence recom- 
mendations for peripheral bypass and angioplasty. The actual relationship between lower 
extremity blood flow and physical functioning, however, has rarely been explicitly studied. 
Methods: Patients were enrolled at a visit to one of 16 vascular surgery offices and clinics that 
participated in a prospective outcomes tudy. A total of 555 patients (445 men and 110 
women) with an abnormal aulde-brachial index (ABI), none of whom had had previous leg 
revascularization r symptoms of rest pain, skin ulcers, or gangrene, completed the SF36 
Health Survey and the Peripheral Arterial Disease Walking Impairment Questionnaire 
(WIQ). Stepwise multiple regression analysis was used to test he statistical significance and 
strength of association between patients' ABI level and SF36 physical functioning (PF) and 
WIQ community walking distance scores, controlledfor sociodemographic characteristics 
and the presence and severity of comorbid conditions. 
Results: Univariate correlations with ABI were modest but significant (PF score, r = 0.12, 
p = 0.004; WIQ distance score, r = 0.18, p < 0.001 ). ABI was a very significant predictor 
of both PF (b = 18.8; p = 0.001) and WIQ scores (b = 0.33; p < 0.0001) in the multiple 
regression analysis. Other positive predictors of PF scores were high-school graduation 
and male sex. Negative predictors of PF scores were heart, lung, and cerebrovascular 
disease; knee arthritis and chronic back pain; and enrollment at a Veterans Administration 
clinic rather than a private community or academic office. 
Conclusion: Cross-sectional findings indicate that a 0.3 improvement in ABI is associated 
with an average improvement of 5.6% in PF or 10.3% in WIQ distance score. However, 
proper selection of individual candidates for interventional therapy, that is, those patients 
who have lower ABIs, lower initial functioning, and fewer disabling comorbidities would 
be predicted to produce a much greater functional benefit. Surgeons hould make a 
rigorous functional evaluation when recommending interventional management of 
daudication. (J Vase Surg 1996;24:503-12.) 
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Over the past decade, there has been a rapid and 
controversial increase in the rates of lower extremity 
surgical bypass and endovascular procedures per- 
formed in patients who have disabling intermittent 
claudication, ls Traditionally, lower extremity inter- 
ventional therapy has been an alternative to foot or leg 
amputation and is most often reserved for patients 
who have leg pain at rest, skin ulcers, or gangrene. ~ 
Today, however, it is increasingly common for pa- 
tients who have disabling claudication to undergo 
surgical or endovascular revascularization procedures 
to enhance their walking ability and, consequently, 
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quality of life. Patient perceptions of physical func- 
tioning, walking impairment, and degree of disability 
will therefore greatly influence recommendations for
lower extremity bypass and angioplasty procedures. 
The actual relationship between leg blood flow and 
physical functioning, however, has rarely been explic- 
itly studied. 
This relationship is complicated by the fact that 
patients who have symptomatic peripheral arterial 
occlusive disease often have disabling comorbid con- 
ditions and are frequently of advanced age. Clinical 
decisions about interventional management of clau- 
dication should therefore hinge on the patients' own 
perceptions of current and potential functional ca- 
pacity after treatment. For this reason, documenta- 
tion of patients' self-reported outcomes of treatment 
that reflects ftmctional status is becoming as impor- 
tant and relevant as more traditional physiologic 
outcome measures such as arterial patency and tread- 
mill testing, s 
This study describes the relationship between leg 
blood flow, as measured by the resting ankle-brachial 
index (ABI), and claudication patients' self-reported 
physical functioning and walking distance, as mea- 
sured by well-established and validated survey instru- 
ments. Data are derived from those patients who 
enrolled in a prospective, multicenter outcomes re- 
search study that involved 16 Chicago-area vascular 
surgery offices and clinics. The study includes one of 
the largest and most diverse cohorts of claudication 
patients yet to be studied in the United States. A 
cross-sectional multiple regression analysis, which 
controlled for a variety of patient sociodemographic 
characteristics and for the severity of comorbid con- 
ditions, is used to test he statistical significance of the 
relationship of the patients' ABI with their physical 
functioning. Implications of results for patient selec- 
tion for interventional management are discussed. 
PATIENTS AND METHODS 
Patients. All patients in this study were enrolled 
from 1993 to 1995 at visits to one of 16 participating 
academic, community, or Veteran's Administration 
vascular surgery offices or clinics. All patients igned 
informed consent forms from the Institutional Re- 
view Boards of the participating institutions. Patients 
who complained of claudication were enrolled after 
examination by participating vascular surgeons if they 
had not undergone a previous leg revascularization 
procedure and if they had no signs of progressive 
disease, such as ischemic rest pain, skin ulcers, or 
gangrene. The diagnosis was confirmed by an abnor- 
mal resting ABI (_<0.94) at the time of the index visit. 
Ankle systolic pressure was computed from blood 
flow laboratory reports as the lowest leg mean of the 
dorsalis pedis and posterior tibial arteries. 6 A total of 
555 patients are included in this report; because of the 
focus on AB1 measurement, approximately 50 other 
enrolled patients who had noncompressible arteries 
but diagnostic waveforms were excluded from the 
present study. 
Surveys. At enrollment, all patients completed 
questionnaires with four separate components. First, 
patients completed the 36-item Medical Outcomes 
Study SF36 Health Survey (SF36). 7 This survey is in 
widespread use throughout the United States and has 
been translated into a number of languages for 
international use. The SF36 has the advantage of 
having been calibrated for the general U.S. adult 
population, as well as for patients who have specific 
chronic conditions. It calculates separate scores from 
0 (worst) to 100 (best) that represent eight discrete 
dimensions of health: physical functioning, physical 
role functioning, emotional role functioning, bodily 
pain, general health perceptions, vitality and fatigue, 
social functioning, and mental health. The primary 
measure of interest in this study is the physical 
ftmctioning (PF) score, a 10-item scale based on 
patients' ratings of the degree of difficulty they have in 
performing moderate and vigorous activities, carry- 
ing groceries, climbing stairs, and walking various 
distances. The mean PF score for the general U.S. 
population is 84.2 (SD, 23.3); the mean for the 
general U.S. male population over 65 years of age is 
65.8, and for women over 65 years of age it is 61.9. 
The Cronbach ix reliability coefficient, which mea- 
sures internal consistency, is 0.93. To provide some 
reference for the scores reported here, only 50% of 
people who have PF scores between 50 and 59 
reported being able to walk one block without limi- 
tation because of health, as opposed to 90% of those 
who have scores between 70 and 79. 7 
The second survey component was the PAD 
Walking Impairment Questionnaire (WIQ), an 11- 
item survey that was designed specifically to analyze 
community walking function for patients who have 
peripheral arterial disease, s Separate speed and dis- 
tance summary scores are computed. The primary 
measure that was used in this study was the distance 
score. The distance score measures the degree of 
difficulty in walking, without stopping to rest, for 
several distances, as far as five blocks. It is scored with 
levels in a 0 (inability to walk) to 1 (unrestricted 
walking ability) range. The summary score for dis- 
tance previously has been found to correlate highly 
with peak treadmill walking time, correlate moder- 
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ately with treadmill time to onset ofclaudication pain, 
and was found to have test-retest reliability and 
sensitivity to changes related to exercise rehabilitation 
and surgical treatment. 9 
The third survey component included a 16-item 
chronic disease checklist hat was derived from the 
National Health Interview Survey. In addition to 
medical history questions, patients were specifically 
asked to rate the degree to which symptoms of 
chronic conditions (e.g., hip or knee arthritis pain, 
sciatica or back pain, deafness or blindness) other than 
peripheral vascular disease interfered with their ability 
to walk. The highest Likert scale measure of comor- 
bidity walking impairment on any symptom was used 
to weight four hierarchical walking difficulty levels 
("very much," "much" "some," "none or slight"). 
These levels ofcomorbidity walking impairment were 
found to be monotonically correlated with SF36 PF 
scores for claudication patients in pilot analyses. 10 The 
final component of the enrollment questionnaires 
consisted of a series of approximately 30 items about 
smoking and exercise habits; the severity, duration, 
and tolerance of leg symptoms; and sociodemo- 
graphic characteristics. 
Statistical analysis. Univariate Pearson product- 
moment correlation coefficients were computed to 
test he correlation of patients' ABI with SF36 PF and 
WIQwalking distance scores. Stepwise ordinary least- 
squares multiple regression analysis was performed to 
test he relationship of ABI with SF36 andWIQ scores 
while controlling for the influence of patient factors 
that would be likely to predict functional status. These 
covariates included sociodemographic characteristics 
(age, sex, race, educational level, living alone), clinic 
enrollment site (Veterans Administration, academic, 
or community), the influence of both a history of 
chronic disease and smoking, the severity ofcomorbid 
walking impairment, and the duration of leg symp- 
toms (greater or less than the approximate mean of 5 
years). Several specifications of chronic disease char- 
acteristics were tested, allowing for the grouping of 
comorbidities by body system. Age was tested as both 
a continuous variable and as a dichotomous variable 
for age greater than 75 years. Exercise habits, employ- 
ment status, and leg symptom severity were excluded 
as candidate variables in regression analysis as a result 
of confounding with dependent measures. 
RESULTS 
Descriptive statistics. Table I presents descrip- 
tive characteristics for the 555 claudication patients at 
study enrollment, including mean SF36 PF and WIQ 
scores for each patient subgroup. The mean SF36 PF 
score for all patients was 45.8 (SD, 22.5), which puts 
this cohort at the approximate lower 25th percentile 
of the U.S. population aged 65 and older. 7 To put the 
overall mean PF score in better perspective, it com- 
pares very unfavorably with patients who had a recent 
(within i year) myocardial infarction (mean PF score, 
69.9; mean age, 59.2 years) and is about equal to 
patients who had congestive heart failure (mean PF 
score, 47.5; mean age, 67.4 years) previously studied 
in the Medical Outcomes Study 7and with a group of 
62 highly ischemic aortobifemoral bypass urvivors. 11 
The mean WIQ score for all patients was 0.32 (SD, 
0.27). This score was less than one third that of a 
younger, healthier population. ~2 
A total of 284 patients (51.2%) were enrolled at 
Veterans Administration clinics; the remainder were 
split about evenly between academic, university-affili- 
ated offices and private community offices. A total of 
110 (19.8%) were female and 91 (16.4%) were 
African-American. Although 322 patients (58%) re- 
ported being ex-smokers, less than one third reported 
being current smokers, and one third reported en- 
gaging in "regular physical activity." The mean age 
was just less than 69 years; 154 patients (27.7%) were 
75 years or older, and 57 patients (10.3%) were 80 
years or older. 
Comorbidities. Table II presents the patients' 
self-reported prevalence of major chronic diseases. 
One third of the patients in the sample population 
reported having diabetes or having symptoms of 
coronary artery disease. More than 20% of patients 
reported having arm or leg weakness, paralysis, or 
cerebrovascular disease symptoms. A total of 88 
patients (15.9%) reported having lung disease 
(chronic bronchitis, asthma, or emphysema). One 
third reported significant knee arthritis or symptoms 
of back pain. When asked specifically about how any 
chronic symptoms affected walking ability, 89 pa- 
tients (16%) reported severe impairment, 100 (18%) 
moderate impairment, and 120 (21.6%) mild impair- 
ment, as opposed to no or slight impairment. 
Because the prevalence of heart failure, myocar- 
dial infarction, or angina frequently overlapped, these 
conditions were grouped as a single candidate variable 
for regression analysis. Similarly, patients who re- 
ported severe weakness or paralysis of the arms or legs 
were grouped with patients who reported cerebrovas- 
cular disease. Knee arthritis and back pain, which had 
significantly lower mean PF and WIQ scores, also 
overlapped considerably and were therefore tested as 
a single candidate variable in regression analysis. 
Leg symptoms and physical functioning. Table 
III presents data on leg symptom severity. The mean 
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Table I. Sociodemographic characteristics (555 patients) 
Mean/frequency SD/percent Mean (SD) PF score* Mean (SD) WIQ scoret 
Mean age 68.8 (SD = 9.8) 45.8 (22.6) 0.32 (0.27) 
Age >74 154 (27.7%) 45.3 (23.1) 0.34 (0.29) 
Male 445 (80.2%) 45.9 (22.4) 0.32 (0.26) 
Female 110 (19.8%) 45.7 (22.6) 0.34 (0.29) 
High-school graduate 419 (75.5%) 45.6 (22.3) 0.33 (0.27) 
Work full/part ime 107 (19.3%) 53.1 (20.5) 0.39 (0.27) 
Married 323 (58.2%) 47.2 (21.8) 0.33 (0.26 
Living alone 153 (27.6%) 44.4 (23.1) 0.33 (0.27 
African-American 91 (16.4%) 39.0 (21.2) 0.31 (0.26 
Past smoker 322 (58.0%) 46.2 (22.7) 0.32 (0.26 
Current smoker 151 (27.2%) 42.6 (20.9) 0.30 (0.25 
Exercise regularly 185 (33.3%) 55.3 (21.6) 0.43 (0.27 
VA clinic patient 284 (51.2%) 42.7 (22.7) 0.31 (0.28 
Academic surgeon office patient 145 (26.1%) 47.6 (23.0) 0.34 (0.27 
Community surgeon office patient 126 (22.7%) 50.9 (20.6) 0.33 (0.28 
*SF 36 health survey physical functioning score, 0 (worst) to 100 (best). 
~fPeripheral arterial disease walking impairment questionnaire, 0 (worst) to 1 (unrestricted). 
Table II. Chronic disease comorbidities (555 patients) 
Mean~frequency SD/percent Mean (SD) PFscore* Mean (SD) WIQscore~ 
Hypertension 381 (68.6%) 45.1 (22.7) 0.31 (0.26) 
Mycardialinfarction 189 (34.0%) 42.8 (21.6) 0.30 (0.24) 
Angina 174 (31.4%) 42.5 (21.8) 0.25 (0.24) 
Congestive heart failure 76 (13.7%) 39.3 (21.3) 0.28 (0.25) 
Diabetes 182 (32.8%) 44.6 (22.8) 0.28 (0.25) 
Arm or leg paralysis/cerebrovascular disease 115 (20.7%) 37.2 (20.1) 0.27 (0.25) 
Cancer (except skin cancer) 80 (14.4%) 44.7 (25.1) 0.28 (0.25) 
Allergies 117 (21.1%) 45.3 (27.1) 0.34 (0.26) 
Knee arthritis 169 (30.5%) 41.0 (23.1) 0.27 (0.26) 
Otherarthriris 254 (45.8%) 43.9 (22.4) 0.31 (0.25) 
Backpain 183 (33.0%) 41.2 (22.4) 0.27 (0.25) 
Lung disease 88 (15.9%) 39.3 (22.5) 0.26 (0.26) 
Skin disease 97 (17.5%) 43.5 (20.3) 0.31 (0.26) 
Impaired hearing 137 (24.7%) 45.7 (27.1) 0.34 (0.27) 
Impaired vision 115 (20.7%) 42.8 (20.9) 0.32 (0.29) 
None-slightcomorbiditywalkingimpairment 246 (44.4%) 49.8 (23.5) 0.36 (0.27) 
MildcomorbiditywaUdngimpairment 120 (21.6%) 48.0 (21.3) 0.35 (0.25) 
Moderate comorbidity walking impairment 100 (18.0%) 45.1 (19.8) 0.31 (0.26) 
Severe comorbiditywalking impairment 89 (16.0%) 34.3 (20.7) 0.23 (0.24) 
*SF 36 health survey physical functioning score, 0 (worst) to 100 (best). 
J'Peripheral rterial disease walking impairment questionnaire, 0 (worst) to 1 (unrestricted). 
ABI was 0.59 (SD, 0.16), with a range of 0.12 to 0.94. 
Patients reported an average of about 5 years of 
claudication symptoms; only 11% reported the onset 
of leg symptoms as having been within I year before 
their index and enrollment visit. Patients who had a 
longer duration of symptoms had significantly lower 
PF (p = 0.02) and WIQ (p = 0.03) scores. 
More than 40% of all patients reported "severe" 
or "very severe" leg symptoms; these patients had 
very significantly lower PF and WIQ scores. The 232 
patients who reported severe leg symptoms had a 
mean PF score of only 36.1 (SD, 20.2), as compared 
with the remaining 323 patients who did not report 
severe leg symptoms (mean PF score, 52.8; SD, 21.5; 
p < 0.001). Patients who reported severe leg symp- 
toms had a mean WIQ distance score of only 0.20 
(SD, 0.20), as compared with the rest of the cohort, 
who had a mean WIQ distance score of 0.41 (SD, 
0.27; p < 0.001). 
Some insight into the variation in disability is 
provided by the responses to the WIQ items on 
one-block, two-block, and three-block distances that 
are presented in Table III. As indicated, 93 patients 
(16.8%) reported being unable to walk even one block 
without stopping to rest. Whereas asmall number of 
study patients reported that they had no restriction i  
walking any of the WIQ distances even as far as five 
blocks, 60 patients (11%) reported that they either 
could not walk 50 feet or had much difficulty in doing 
so. A total of 233 patients (42%) reported not being 
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Table  I I I .  Lower extremity disease severity and physical functioning (555 patients) 
Mean~frequency SD/percent Mean (SD) PF score* Mean (SD) WIQ scoret 
Mean lowest leg ankle-brachial 0.59 (SD = 0.16) 45.8 (22.6) 0.32 (0.27) 
index 
Leg symptoms " evere or very 232 (41.8%) 36.1 (20.2) 0.20 (0.20) 
severe" 
Leg symptom duration <5 yr 332 (59.8%) 47.1 (22.5) 0.34 (0.27) 
Difficulty walking one block 
without stopping to rest 
Could not do 93 (16.8%) 28.4 (20.8) 0.03 (0.07) 
Much difficulty 135 (24.3%) 37.1 (19.9) 0.17 (0.13) 
Some difficulty 203 (36.6%) 49.8 (18.0) 0.36 (0.18) 
No difficulty 124 (22.3%) 62.0 (19.8) 0.65 (0.20) 
Difficulty walking two blocks 
without stopping to rest 
Could not do 173 (31.2%) 32.0 (20.4) 0.05 (0.04) 
Much difficulty 174 (31.4%) 44.8 (19.0) 0.27 (0.11) 
Some difficulty 150 (27.0%) 56.4 (18.3) 0.52 (0.15) 
No difficulty 58 (10.5%) 63.2 (23.0) 0.79 (0.16) 
Difficulty walking three blocks 
without stopping to rest 
Could not do 233 (42.0%) 34.9 (20.4) 0.08 (0.07) 
Much difficulty 180 (32.4%) 47.6 (19.0) 0.34 (0.09) 
Some difficulty 109 (19.6%) 62.6 (17.5) 0.64 (0.10) 
No difficulty 33 (5.9%) 59.0 (26.3) 0.89 (0.10) 
*SF 36 health survey physical functioning score, 0 (worst) to 100 (best). 
1"Peripheral arterial disease walking impairment questionnaire, 0 (worst) to 1 (unrestricted). 
Table  IV.  Stepwise multiple regression model  o f  SF-36 physical functioning score baseline 
enrol lment data ( 5 5 5 patients) 
Variable Coefficient SE p 
Lowest leg ABI 18.8 5.7 0.001 
Male 5.1 2.6 0.047 
High-school graduate 4.8 2.1 0.025 
Severe comorbidity walking impairment -10.1 2.5 <0.001 
Paralysis/CVD -8,0 2.3 <0.001 
COPD -5.0 2.5 0.045 
CHF/CAD -4.2 1.8 0.022 
Knee arthritis/back pain -3.7 1.8 0.040 
VA clinic patient -5.5 2.1 0.008 
Constant 37.7 4.2 <0.001 
R 2 = 14.5. 
CVD, History of cerebrovascular disease; COPD, History of coronary obstructive pulmonary disease; CHF/CAD, history of congestive 
heart failure/coronary artery disease (myocardial infarction or angina). 
able to walk three blocks without stopping to rest, and 
another 18 0 (32.4%) reported having much difficulty 
at three blocks. Only two patients reported SF36 PF 
scores of  100; ten reported scores of  zero, indicating 
they were "l imited a lot"  in all physical activities. A 
total o f  140 patients (25.2%) reported being "l imited 
a lot"  in walking one block on the SF36. 
Corre la t ion  o f  b lood  f low w i th  funct ion ing.  
The univariate correlation o f  ABI with SF3 6 PF scores 
was r= 0.12 (p - -0 .004) .  Univariate regression o f  
ABI on PF score indicated a modest  but significant 
positive correlation. The univariate regression line is 
plotted in Fig. 1. The univariate correlation of  ABI 
with the PAD WIQ distance score was slightly higher 
( r = 0.18; p < 0.001 ). This univariate regression line 
is plotted in Fig. 2. As expected, PF scores (which 
include items that relate to activities o f  daily living and 
upper body disability) correlated highly ( r= 0.51; 
p < 0.0001) with WIQ scores (based on the ability to 
walk distances without stopping to rest). 
Because functioning is known to be influenced by 
a number  of  other factors, stepwise multiple regres- 
sion was used to test the significance of  ABI in 
predicting PF scores controlled for a total o f  22 
candidate covariates. These candidate variables in- 
cluded indicator variables for symptom duration of  
less than 5 years and the categorical variables pre- 
sented in Tables I and I I ,  excluding regular exercise, 
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Fig. 1. Univariate correlation ofSF36 PF score and lowest leg ABI in 555 claudication patients 
(r = 0.12; p = 0.004). Regression equation is PF score = 17.6 (ABI) + 35.4 (95% confidence 
interval, 5.8 to 29.4; p -- 0.003). 
which is confounded with the dependent PF score. All 
these model candidate covariates were believed a 
priori to potentially affect functioning; the standard 
stepwise criteria o fp  < 0.05 was used to retain vari- 
ables in the model. 
Table IV presents the resulting model of PF scores 
with all nine significant variables (p < 0.05). ABI was 
a highly significant (p = 0.001 )predictor of  PF scores. 
The 18.8 __ 5.7 regression coefficient indicates the 
predicted change in PF score associated with a change 
in ABI. Because the ABI can only vary between 0 and 
1.0, this can be interpreted as predicting a clinically 
meaningful 5.6-point improvement in PF score for a 
0.3 improvement in ABI. The other positively asso- 
ciated variables were male sex, which was associated 
with a 5.1-point higher PF score (_+2.6), and having 
completed high school (4.8 __ 2.1). Negatively asso- 
ciated variables were the presence of a severe comor- 
bidity walking impairment (-10.1 + 2.5), as com- 
pared with other comorbidity impairment severity 
levels, arm or leg paralysis or cerebrovascular disease 
(-8.0 + 2.3), a history of lung disease (-5.0 + 2.5), a 
history of congestive heart failure or coronary artery 
disease (-4.2 + 1.8), a history of knee arthritis or 
chronic back pain (-3.7 + 1.8), and enrollment into 
the study at a Veterans Administration clinic 
(-5.5 + 2.1) as opposed to community or academic 
practices. Candidate variables that failed to reach 
significance were age greater than 74 years, living 
alone, African-American race, smoking, duration of 
symptoms, and other comorbidities including other 
arthritis. The model explained just greater than 14% 
of the variance in PF scores, which is consistent with 
other cross-sectional multivariate analyses of SF36 
scores. 1s 
The model of WIQ scores provided results that 
were essentially similar as far as significant predictor 
variables, but explained even less of the variance in 
scores. ABI was highly significant in the WIQ model, 
with a coefficient of 0.33 + 0.07 (p < 0.0001). This 
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Fig. 2. Univariate correlation of WIQ walking distance score and lowest leg ABI in 555 
claudication patients (r=0.18; p< 0.001). Regression equation is WIQ score--0.31 
(ABI) + 0.14 (95% confidence interval, 0.17 to 0.45; p < 0.0001). 
indicates that a predicted 10.3% increase in walking 
distance score is associated with a 0.3 increase in ABI. 
Although Veterans Administration clinic, high-school 
education, and male sex were not quite significant in 
the WIQ score model, diabetes was a significant 
negative predictor (-0.05 _+ 0.02; p = 0.04). 
DISCUSSION 
The relationship of leg blood flow and exercise 
capacity is known to be complex and contradictory. 
On the one hand, studies of exercise training fre- 
quently document substantial gains in claudication 
patients' walking ability without corresponding im- 
provement in peripheral hemodynamics. 14 On the 
other hand, the aim ofinterventional management of
claudication is to improve functional capacity by 
improving blood flow. Even this relationship, how- 
ever, has rarely been well documented. A significant 
relationship between resting ABI and maximal graded 
treadmill walking time (r-- 0.31; p < 0.001) previ- 
ously was reported for claudication patients in one 
other study, is The same investigators, however, re- 
ported no significant correlation between a 0.37 
mean change in resting ABI and a mean 58% improve- 
ment in WIQ distance scores for 14 surgical bypass 
patients who were studied 12 weeks after surgery. 9 
Clearly, the relationship of blood flow and function- 
ing is mediated by a number of other sociodemo- 
graphic and clinical factors, such as age, comorbid 
conditions, and the ability to adjust o disability over 
time. 
The regression results given above indicate the 
existence of a modest but significant relationship 
between one measure of leg blood flow--the ABI- -  
and patients' self-reported physical functioning and 
walking ability, after controlling for a number of 
factors. It is important o note that the regression 
results given above refer to mean effects across the 
entire sample. The average ffect of ABI on PF score 
is therefore not equivalent o predicted effects of 
JOURNAL OF VASCULAR SURGERY 
510 Feinglass et al. October 1996 
improving ABI for a selected subgroup of these pa- 
tients. For instance, as can be seen in Figs. 1 and 2, a 
large number of patients had very low PF or WIQ 
scores but relatively high ABIs (e.g., in the 0.8 to 0.9 
range). Similarly, a number of patients who had rela- 
tively low ABIs (e.g., in the 0.4 to 0.6 range) reported 
relatively high functioning levels and walking capacity. 
These patients would be unlikely to benefit much 
from interventional management to improve blood 
flow. This leaves the subgroup of patients who had 
poor limb blood pressure and poor functioning (the 
lower left quadrant of Figs. 1 and 2) as the best candi- 
dates for interventional therapy. Among such patients 
are those who would already be recognized by clinical 
judgment as the patients most able to benefit from 
bypass urgery or angioplasty--younger, healthier pa- 
tients who have relatively severe leg symptoms and 
less severe comorbid conditions. Although the results 
of this cross-sectional study should be considered 
purely speculative, these patients would be predicted 
to experience far more of an improvement than the 
average gain in PF scores predicted for the whole 
sample (five to six PF points per 0.3 change in ABI). 
There are a number of important limitations to 
these data. First, survey scores were obtained at the 
time of clinic or office visit by patients who were 
seeking medical attention for leg symptoms. These 
scores may thus reflect a lower baseline and would 
potentially be subject o regression to the mean (i.e., 
be higher on average for subsequent administrations 
of the surveys). The ABI measurements, although 
highly reliable with a standard eviation of approxi- 
mately 0.16, may also be subject o significant fluc- 
tuation when repeated over time. Much of the clinical 
data here were self-reported by the patients and may 
thus be subject o recall and other biases, although 
these biases has not been found to be a major problem 
when comparisons were made with available medical 
records. Finally, the available data do not allow 
comparison of the approximate one third of patients 
who had aortoiliac disease and other patients who had 
femoropopliteal or infrapopliteal arterial stenoses. 
Few differences, however, were found between these 
groups in pilot analyses, m 
Outcomes research and monitoring techniques 
based on patient self-reported health status will play 
an increasingly important role in vascular surgery. 
Given the consensus that intermittent claudication 
rarely progresses to limb-threatening ischemia, the 
use of invasive revascularization procedures remains 
controversial. This situation requires surgeons to 
undertake a rigorous functional assessment of patients 
who are seeking relief from disabling symptoms and 
to be sensitive to the patients' own preferences about 
the risks and benefits ofinterventional management. 
The findings presented here suggest that major co- 
morbid conditions uch as cerebrovascular, lung, and 
neurologic disease and knee and back arthritis in- 
fluence claudication patients' functioning and walk- 
ing ability independently of limb blood pressure as 
measured by the ABI. Knowledge of limiting co- 
morbid symptoms is therefore critical in planning 
these patients' management. 
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DISCUSSION 
Dr. D. Eugene Strandness (Seattle, Wash.). This 
paper addresses important aspects of our patients' disabili- 
ties and makes use of a physical functioning score (PF) and 
walking impairment questionnaire (WIQ). As noted, these 
scores were computed from 10 survey items about the 
degree of difficulty that patients experienced in performing 
moderate or vigorous activities uch as lifting, climbing 
stairs, walking, bathing, and dressing. 
The mean PF score was lower in those patients who 
initially reported severe or very severe leg symptoms. 
Interestingly, there was a relationship between ABI, patient 
age, and the PF and WIQ scores. Most importantly, the ABI 
remained significantly associated with a lower PF score after 
controlling for some of the important variables, as noted by 
the authors. If the ABI was lower than 0.4, it was associated 
with a 5.4% lower PF score. Conversely, an increase in the 
ABI of 0.3 was associated with a 5.6% improvement i  the 
PF score and a 10.3% improvement i  the WIQ score. 
What does one make of all this? ABI does reflect he 
magnitude, if you will, of the underlying occlusive disease. 
What it does not do is tell you at what levels the disease isto 
be found or what its pattern is. We also know that changes 
in the ABI do reflect changes in the disease status. It is 
interesting that attempts o use the ABI to predict patients' 
long-term outcome have not been uniformly successful. I 
have always thought that the level of the ABI and absolute 
ankle systolic pressure levels were of clinical value by 
confirming the severity of a patients problem. I have also 
used it as a rough guide for follow-up urposes. 
The severity ofclaudication a d the amount the disease 
restricts walking is traditionally very subjective. We have 
used city blocks as our template, but of course city blocks 
vary in length and are thus a very poor standard. What about 
the treadmill? In my experience it can be of help, but again, 
one cannot necessarily relate the walking time to the degree 
of disability apatient has. Furthermore, it is not at all clear 
how well treadmill walking time relates to quality of life. 
It is interesting to me that a quantitative measure such 
as the ABI correlates this well with the subjective assessment 
by the patient. Perhaps patients do in fact know what they 
are talking about. 
The main question I have is how would one apply this 
in practice? Do you think we may have to reassess the way in 
which we use the patients' historical data and the ABI in 
terms of recommending therapy? How do you think tread- 
mill walking time might compare with the parameters you 
are now using? As you note, there are many instances in 
which the correlation is very poor and would thus be 
misleading if used rigidly. If the data are used intelligently, 
however, it could serve as a useful template in practice. 
Finally, I hope that some attempt might be made to examine 
the effects of level of disease on these scores and their 
relationship to factors uch as the ABI. 
Dr. John M. Porter (Portland, Ore.). Why did you 
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choose an ABI of 0.94? Did you insist on any ankle pressure 
decrease to define the condition ofclaudication? You cannot 
really rely on simple ABI to define claudication. You need to 
define a pressure drop in response to walking. 
In general, I am concerned about outcome question- 
naires. Vascular surgery patients are not very smart. Think 
about he number of bank presidents and executives you see 
in your practice. It's very, very low. 
In fact, there was an important demographic study from 
London published in the British Journal of Surgery in the 
last 3 months that looked at the socioeconomic status of 
vascular patients, and as a group they are extremely low. 
Filling out these questionnaires calls for an enormous 
subjective ffort on the part of the individual. 
I think you have got to be very careful about "garbage 
in, garbage out" on this kind ofsurveyinformation. I assure 
you that a nurse who is helping a vascular patient fill out the 
questionnaire can get you precisely any answer you want by 
how the question is posed to the individual and how the 
question is explained. 
In summary, I have reservations about the ability of 
most of our vascular patients to accurately interpret and 
record answers to these challenging questions. 
Dr. Wiley F. Barker (Los Angeles, Calif.). I just have 
one short question. Did Dr. McCarthy evaluate the pa- 
tients' weights, the overall spectrum of their weights, and 
any changes in weight? 
Dr. J. Dennis Baker (Los Angeles, Calif.). I have 
trouble proposing intervention with an average improve- 
ment in walking distance of only 10%. Is there a problem 
with the model or are we really dealing with low expected 
benefit? 
Dr. Walter J. McCarthy. Thank you for all the insight- 
ful comments. Responding to Dr. Strandness, I think that 
one way we can use this information is to think about 
people's comorbidities before we recommend treatment to 
them. As an example, a patient who has hemiparesis would 
not be recommended to have a revascularization procedure 
for claudication, and we should carefully screen our patients 
for such things as hip and knee arthritis and congestive heart 
failure. 
The question about readmill correlation with the SF36 
and the walking impairment questionnaire is a good one. 
There has been work by Regensteiner and Hiatt with a 
graduated treadmill where the grade is increased over time 
as the patient exercises. There is a reasonable correlation, at 
least with the walking impairment questionnaire, in their 
study. 
The level of disease is an important one, and I was a bit 
surprised that we had difficulty showing a difference be- 
tween iliac occlusion and superficial femoral artery occlu- 
sion. About two thirds of the patients have occlusion of the 
superficial femoral artery, and about a third of them have 
lilac claudication. 
Dr. Porter questioned the use of 0.94 as an upper ange 
for the ABI. The mean of all the ABIs was 0.59, and 
although 0.94 is somewhat arbitrary it has been used in 
other studies. There are patients who have an ankle index in 
that area who have ischemia when they walk. 
The most formal way to design a study like this would 
be to conduct periodic graduated treadmill testing sessions 
for all of the patients. We did not have the resources to do 
graduated treadmill testing for all of the patients, but notice 
that in almost all practice settings claudication is diagnosed 
by history and ABI. 
Dr. Barker asked about the weight changes in patients, 
and although I did not look at weight changes, I am able to 
put them into the follow-up questionnaires. 
Our modeling suggests roughly a 10% increase in the 
overall performance with treatment. The 10% increase 
applies to the entire group. If we were able to screen 
patients knowing which ones would benefit he most, the 
increase will be much more. By selecting the patients more 
accurately we should get increases in performance after 
treatment. 
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